05.06.2018 23:51:00
|
Lifshitz & Miller LLP Announces Investigation of ACETO Corporation, Esperion Therapeutics, Inc., Flex Ltd., Kulicke and Soffa Industries, Inc., Macquarie Infrastructure Corporation, Mercury...
NEW YORK, June 5, 2018 /PRNewswire/ --
ACETO Corporation (ACET)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with announcement that ACETO's financial guidance should no longer be relied upon and that Edward Borkowsky resigned as CFO.
If you are an ACETO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Esperion Therapeutics, Inc. (ESPR)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with the 13 deaths in Esperion's trial for its cholesterol-lowering medication.
If you are an Esperion investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Flex Ltd. (FLEX)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with Flex's independent investigation of allegations of improper accounting of obligations in a customer contract.
If you are a Flex investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Kulicke and Soffa Industries, Inc. (KLIC)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with certain alleged unauthorized transactions and the delayed filing of its SEC quarterly report.
If you are a KLIC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Macquarie Infrastructure Corporation (MIC)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with the reduced dividened and repurpose of some of its assets.
If you are a Macquarie investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Mercury Systems, Inc. (MRCY)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with a report asserting that Mercury "appears to be caught in the perfect storm of slowing growth, rising costs and debt."
If you are a Mercury investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Ormat Technologies, Inc. (ORA)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with the restatement of its financial statements due to "errors" in Ormat's income tax provision.
If you are an Ormat investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Prothena Corporation PLC (PRTA)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with PRTA discontinuing development of NEOD001.
If you are a Prothena investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
ATTORNEY ADVERTISING. © 2018 Lifshitz & Miller LLP. The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
SOURCE Lifshitz & Miller Law Firm
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Esperion Therapeutics Incmehr Nachrichten
06.11.24 |
Ausblick: Esperion Therapeutics zieht Bilanz zum abgelaufenen Quartal (finanzen.net) | |
11.08.24 |
Ausblick: Esperion Therapeutics informiert über die jüngsten Quartalsergebnisse (finanzen.net) | |
28.07.24 |
Erste Schätzungen: Esperion Therapeutics vermeldet Zahlen zum jüngsten Quartal (finanzen.net) |
Analysen zu Esperion Therapeutics Incmehr Analysen
Aktien in diesem Artikel
Esperion Therapeutics Inc | 2,13 | 4,83% | |
Flextronics International Ltd. | 37,28 | 3,95% | |
Kulicke & Soffa Industries Inc. | 45,34 | 0,98% | |
Mercury Systems Inc. | 38,40 | 1,05% | |
Ormat Technologies Inc. | 65,24 | -0,03% | |
Prothena Corporation PLC | 14,70 | -3,29% |